HCA Healthcare Inc (NYSE:HCA) has earned an average recommendation of “Buy” from the twenty-three analysts that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and eighteen have given a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $151.45.
Several research firms have recently weighed in on HCA. Goldman Sachs Group downgraded EXPERIAN PLC/ADR from a “buy” rating to a “neutral” rating in a research report on Wednesday, July 10th. Jefferies Financial Group set a $158.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Deutsche Bank cut Hilton Hotels from a “buy” rating to a “hold” rating and set a $92.60 price objective for the company. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Zacks Investment Research upgraded GALP ENERGIA SG/ADR from a “sell” rating to a “hold” rating in a research note on Monday, May 27th. Finally, Raymond James set a $86.00 price target on Gilead Sciences and gave the company a “buy” rating in a research note on Tuesday, April 23rd.
In other news, insider Jon M. Foster sold 44,281 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the completion of the sale, the insider now directly owns 96,052 shares in the company, valued at $11,745,238.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.70% of the stock is currently owned by corporate insiders.
HCA Healthcare stock traded down $1.75 on Tuesday, hitting $139.48. 1,092,731 shares of the stock traded hands, compared to its average volume of 1,355,820. The stock has a market capitalization of $47.74 billion, a price-to-earnings ratio of 14.28, a P/E/G ratio of 1.12 and a beta of 0.80. The firm has a fifty day moving average of $132.37. HCA Healthcare has a 1 year low of $107.04 and a 1 year high of $147.42.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, April 30th. The company reported $2.97 EPS for the quarter, topping the consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The company had revenue of $12.52 billion during the quarter, compared to the consensus estimate of $12.34 billion. During the same period last year, the company earned $3.18 EPS. HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, sell-side analysts predict that HCA Healthcare will post 10.39 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Monday, June 3rd were issued a $0.40 dividend. The ex-dividend date of this dividend was Friday, May 31st. This represents a $1.60 annualized dividend and a yield of 1.15%. HCA Healthcare’s dividend payout ratio is currently 16.38%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: What is a Stop Order?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.